SCHEMBL9404802

SCHEMBL9404802

COc1ccc(C(=O)Oc2ccc(CCN)cc2OC(=O)c2ccc(OC)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.58
TAAR1 Q96RJ0 3/20 0.54
KDM4E B2RXH2 1/20 0.54
ATM Q13315 1/20 0.54
TSHR P16473 2/20 0.51
MAPK1 P28482 1/20 0.51
LMNA P02545 4/20 0.51
NPC1 O15118 3/20 0.51
HTT P42858 2/20 0.51
CCR5 P51681 1/20 0.51
MAOB P27338 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
GLA P06280 2/20 0.50
NFKB1 P19838 1/20 0.50
MEN1 O00255 1/20 0.49
APEX1 P27695 1/20 0.49
MAPT P10636 4/20 0.47
ALOX12 P18054 1/20 0.47
ALDH1A1 P00352 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9404906 0.86 CCR5 (0.49) KMT2ATAAR1KDM4EATMTSHR
SCHEMBL28044188 0.83 KDM4E (0.62) KMT2ATAAR1KDM4EATMTSHR
SCHEMBL9404994 0.82 KMT2A (0.53) KMT2ATAAR1KDM4EATMTSHR
SCHEMBL9404886 0.82 KMT2A (0.56) KMT2ALMNANPC1HTTCCR5
Hydrochloric Acid SCHEMBL16049971 0.81 KMT2A (0.52) KMT2ATAAR1KDM4EATMTSHR
SCHEMBL31321697 0.81 KMT2A (0.71) KMT2ALMNANPC1HTTCYP1A2
SCHEMBL9404960 0.81 KMT2A (0.55) KMT2ALMNANPC1HTTCCR5
SCHEMBL9404899 0.81 KMT2A (0.55) KMT2ALMNANPC1HTTCCR5
SCHEMBL17933786 0.81 KMT2A (0.69) KMT2ALMNANPC1CYP1A2CYP3A4
SCHEMBL31321632 0.78 KMT2A (0.58) KMT2ATSHRMAPK1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0431942-B1 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative SANSHO CO (JP) 1994-03-23 EP disclosed
US-5246949-A And lactic acid esters, treatment of hypotension and cardiac circulatory insufficiency SANSHO CO., LTD. (JP) 1993-09-21 US disclosed
EP-0431942-A2 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative SANSHO CO., LTD. (JP) 1991-06-12 EP disclosed